A Look Into AbbVie Inc's Price Over Earnings - AbbVie ( NYSE:ABBV )
In the current session, the stock is trading at $233.57, after a 0.52% spike. Over the past month, AbbVie Inc. ( NYSE:ABBV ) stock increased by 0.94%, and in the past year, by 40.22%.
Nvidia and 19 Other Stocks Now Make Up 50% of the S&P 500. Here's What It Means for Your Investment Portfolio.
Buying the S&P 500 takes the belief that today's leading companies deserve their lofty valuations.
AbbVie Stock Falls 4% -- What Investors Need to Know
It's no reason to stay up at night.
This Sector Is Suddenly Crushing the Broader Market. Should You Invest $1,000?
Healthcare stocks have far outperformed the broader market over the past month.
James M. O'Brien Appointed Chief Financial Officer at Mesoblast - Mesoblast ( NASDAQ:MESO )
NEW YORK, Nov. 17, 2025 ( GLOBE NEWSWIRE ) -- Mesoblast Limited ( NASDAQ:MESO, ASX:MSB ) ) , global leader in allogeneic cellular medicines for inflammatory diseases, today announced that in connection with the Company's transition to a fully integrated commercial organization it has appointed ...
James M. O'Brien Appointed Chief Financial Officer at Mesoblast
NEW YORK, Nov. 17, 2025 ( GLOBE NEWSWIRE ) -- Mesoblast Limited ( Nasdaq:MESO. ASX:MSB ) , global leader in allogeneic cellular medicines for inflammatory diseases, today announced that in connection with the Company's transition to a fully integrated commercial organization it has appointed ...
The Schwab U.S. Dividend Equity ETF ( SCHD ) Offers a Higher Yield and Lower Cost Than the iShares Core High Dividend ETF ( HDV )
The iShares Core High Dividend ETF ( NYSEMKT:HDV ) and the Schwab U.S. Dividend Equity ETF ( NYSEMKT:SCHD ) both focus on U.S. dividend stocks, but SCHD stands out for its lower cost, higher yield, and much larger assets under management, while HDV has shown stronger recent returns.Both the ...
These 2 Dividend ETFs Are a Retiree's Best Friend
Exchange-traded funds provide investors with exposure to a basket of stocks. Some also pay dividends.
Want Decades of Passive Income? 3 Stocks to Buy Now and Hold Forever.
These stocks pay income that investors can count on over the long run.
AbbVie Partners with Award-Winning Filmmaker on Film About the Dynamic and Resilient Lives of Those Living with Blood Cancer - AbbVie ( NYSE:ABBV )
Film captures inspiring journeys of three individuals living with chronic lymphocytic leukemia ( CLL ) CLL is one of the most common leukemias among adults affecting more than 200,000 people in the United States1,2 Film premiered yesterday in Los Angeles, hosted by actor and advocate Jesse ...
Can Lilly's Next-Gen Obesity Drugs Help Sustain Its Market Dominance?
Eli Lilly's next-gen obesity drugs, led by oral orforglipron and triple-acting retatrutide, aim to reshape the fast-growing weight-loss market.
Pharma ETFs in Spotlight Following Robust Q3 Earnings Results
Pharma ETFs like IHE and PPH are rallying as strong Q3 earnings across major pharmaceutical companies lift sector sentiment.
IRWD Rises 110% in a Month: Should You Buy, Sell or Hold the Stock?
Ironwood's 110% monthly surge follows upbeat third-quarter results and raised 2025 outlook, powered by increasing Linzess demand.
Stock Market News for Nov 13, 2025
Wall Street closed mixed on Wednesday, pulled up by healthcare and financial stocks.
Shine a Light on Healthcare ETFs Amid National Alzheimer's Awareness Month
As National Alzheimer's Awareness Month spotlights new treatments, healthcare ETFs like XLV and VHT might gain fresh investor appeal.
Xilio Therapeutics Announces Pipeline and Business Updates and Third Quarter 2025 Financial Results
Reported late-breaking Phase 2 data at SITC for vilastobart demonstrating a 40% ORR in heavily pretreated patients with MSS mCRC without liver metastases and high plasma tumor mutational burden ...
Is the Schwab U.S. Dividend Equity ETF the "Ultimate Retirement Fund" for Investors?
A $10,000 investment in this diversified fund at its 2011 inception would be worth $51,000 today.
2 Strong Healthcare Stock Picks for Dividend Investors
These top dividend payers could enrich a long-term investor's portfolio.
Alvotech Reports Results for the First Nine Months of 2025 and Provides a Business Update
REYKJAVIK, Iceland, November 12, 2025 - Alvotech ( NASDAQ: ALVO, or the "Company" ) , a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today reported financial results for the first nine months of 2025 and provided a summary ...
Alvotech Reports Results for the First Nine Months of 2025 and Provides a Business Update
REYKJAVIK, Iceland, Nov. 12, 2025 ( GLOBE NEWSWIRE ) -- Alvotech ( NASDAQ: ALVO, or the "Company" ) , a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today reported financial results for the first nine months of 2025 and ...
AbbVie Shares Rise To Intraday High After Key Trading Signal - AbbVie ( NYSE:ABBV )
AbbVie Inc ( NYSE:ABBV ) experienced a significant Power Inflow alert, a key bullish indicator that is closely tracked by traders who value order flow analytics, specifically institutional and retail order flow data. At 10:04 AM EST on November 12, ABBV triggered a Power Inflow signal at a price ...
How Much Did Skyrizi and Rinvoq Drive AbbVie's Q3 Performance?
ABBV's growth engine keeps humming as Skyrizi and Rinvoq together now power more than 40% of total revenues and drive new market share gains.
3 Cohen & Steers Mutual Funds Deserve a Place in Your Portfolio
Invest in Cohen & Steers mutual funds like PISHX, LPXFX and CSRSX for long-term returns.
LB Pharmaceuticals Appoints Kaya Pai Panandiker as Chief Commercial Officer
NEW YORK, Nov. 12, 2025 ( GLOBE NEWSWIRE ) -- LB Pharmaceuticals, Inc ( "LB Pharmaceuticals" or the "Company" ) ( Nasdaq: LBRX ) , a clinical-stage biopharmaceutical company developing novel therapies for schizophrenia, bipolar depression, and other neuropsychiatric diseases, today announced the ...
LB Pharmaceuticals Appoints Kaya Pai Panandiker as Chief Commercial Officer - LB Pharmaceuticals ( NASDAQ:LBRX )
NEW YORK, Nov. 12, 2025 ( GLOBE NEWSWIRE ) -- LB Pharmaceuticals, Inc ( "LB Pharmaceuticals" or the "Company" ) ( NASDAQ:LBRX ) , a clinical-stage biopharmaceutical company developing novel therapies for schizophrenia, bipolar depression, and other neuropsychiatric diseases, today announced the ...
Psyence BioMed Establishes Ibogaine Operations in Africa Through Strategic Investment in PsyLabs - Psyence Biomedical ( NASDAQ:PBM )
NEW YORK, Nov. 12, 2025 ( GLOBE NEWSWIRE ) -- Psyence BioMed ( NASDAQ:PBM ) ( "Psyence BioMed" or the "Company" ) , a biopharmaceutical company advancing nature-derived psilocybin and ibogaine therapies for unmet mental health needs, today announced that, through its strategic investment in ...
Want $1 Million in Retirement? 3 Simple Index Funds to Buy and Hold for Decades
These funds go well together, enabling you to grow your retirement nest egg on easy mode.
This Unstoppable Growth Stock Just Delivered More Good News: Time to Buy?
This drugmaker's innovation engine continues to operate at full capacity.
NEXGEL ( NXGL ) Q3 2025 Earnings Call Transcript
Image source: The Motley Fool.Tuesday, November 11, 2025 at 4:30 p.m. ETNeed a quote from a Motley Fool analyst? Email [email protected] reading ...
Three Healthcare Buys That Wall Street Loves
These three healthcare stocks are outperforming most of the sector.
Lilly Up 18% in a Month: Should You Buy, Sell or Hold the Stock?
Eli Lilly stock jumps 18% in a month as strong Q3 results, upgraded guidance and rising demand for Mounjaro and Zepbound fuel investor optimism.
IRWD Beats on Q3 Earnings & Revenues, Raises 2025 View, Stock Soars
Ironwood posts a stellar third-quarter beat with higher revenues and raises 2025 outlook on Linzess-driven strength.
5 Top Stocks to Buy in November
All 5 stocks have upside potential heading into 2026.
Is Invesco Pharmaceuticals ETF ( PJP ) a Strong ETF Right Now?
Smart Beta ETF report for ...
Senate's Deal Signals Potential End to US Govt. Shutdown: Top ETFs to Buy
A bipartisan Senate deal signals an end to the U.S. government shutdown, sparking investor interest in ETFs like XLV and SPY.
Does Trump's MFN Policy Put Pharma ETFs in the Crosshairs?
With Trump's MFN policy cutting U.S. drug prices, will Pharma ETFs such as IHE, heavily weighted toward Eli Lilly and Novo Nordisk, lose momentum?
Is ProShares S&P 500 Dividend Aristocrats ETF ( NOBL ) a Strong ETF Right Now?
Smart Beta ETF report for ...
What Is Considered a Good Stock Dividend? 3 Healthcare Stocks That Fit the Bill.
Healthcare stocks in the S&P 500 offer an average dividend yield of 1.8%.
Got $5,000? These Are 3 of the Cheapest Growth Stocks to Buy Right Now
These stocks are priced low, have encouraging growth prospects, and also pay dividends.
Is the Schwab U.S. Dividend Equity ETF a Buy Now?
Not every investor will like this exchange-traded fund. But many will.
LLY's GLP-1 Duo Boosts Sales Amid Rising Demand for Obesity Drugs
Lilly's Mounjaro and Zepbound continue to power growth as new launches boost momentum amid rising obesity competition.
Xilio Therapeutics Announces Late-Breaking Phase 2 Data for Vilastobart in Patients with MSS mCRC and High Plasma Tumor Mutational Burden at Society for Immunotherapy of Cancer ( SITC ) 40th Annual Meeting
40% ORR in heavily pre-treated patients with MSS mCRC without liver metastases and with high plasma tumor mutational burden ...
Xilio Therapeutics Highlights Portfolio of Differentiated Masked Immunotherapies at Society for Immunotherapy of Cancer ( SITC ) 40th Annual Meeting
Preclinical data support best-in-class potential of masked T cell engager programs and platform utilizing Xilio's ATACR and SEECR formats, including efficient masking, potent anti-tumor activity and broad therapeutic index ...
Dr. Adrian Bot joins Immuthera to support the company with his unique experience in commercialization of groundbreaking cell therapies
Immuthera, operating in the United States, is a wholly owned subsidiary of PolTREG S.A. a leader in innovative immune therapies with focus on regulatory T cell technologies. In addition, Dr. Bot will serve as Scientific Advisor of PolTREG S.A., leveraging his experience in development and ...
Dr. Adrian Bot joins Immuthera to support the company with his unique experience in commercialization of groundbreaking cell therapies
Dr. Adrian Bot joins Immuthera to support the company with his unique experience in commercialization of groundbreaking cell therapies Dr. Adrian Bot, a renowned biopharmaceutical founder and scientist, has joined Immuthera's Board of Directors to strengthen its pipeline development and ...
Genmab Announces Financial Results for the Nine Months of 2025
November 6, 2025 Copenhagen, Denmark. Interim Report for the Nine Months Ended September ...
Evolus ( EOLS ) Q3 2025 Earnings Call Transcript
Image source: The Motley Fool.Wednesday, Nov. 5, 2025, at 4:30 p.m. ETNeed a quote from a Motley Fool analyst? Email [email protected] reading ...
3 Dividend Stocks Down 11%, 29%, and 41% to Buy in November
These stocks aren't popular right now, but their strong underlying businesses make them hot deals to pounce on.
Eli Lilly to start late-stage trials on amylin obesity drug after it shows up to 20% weight loss in study
The highest dose of Eli Lilly's weekly injection helped patients with obesity or who are overweight lose 20.1% of their body weight on average at 48 weeks.
Acadia ( ACAD ) Q3 2025 Earnings Call Transcript
Image source: The Motley Fool.Wednesday, Nov. 5, 2025 at 4:30 p.m. ETChief Executive Officer - Catherine Owen AdamsContinue reading ...
